Sixty-four steer calves were individually fed in a 181-day experiment to determine their gain, feed efficiency, plasma urea-N and seminal vesicle response following implantation with 30 mg of either stilbene, estriol, estrone, 16-estradiol, c~-estradiol or diethylstilbestrot (DES). Half of the steers were fed a constant level and the remaining half were fed a declining level of supplemental protein providing 1.5, 1 and .5 times that of the constant level of supplemental protein.
INTRODUCTION
Estrogenic compounds have been known for some time to increase gain and feed efficiency of cattle and sheep, however, it is unclear whether estrogenic activity is required for gain stimulation (Preston, 1975) . Several compounds are structurally similar to DES and /3-estradiol but elicit little or no estrogenic response. These may be useful, however, in delineating whether estrogenic potency is required for the growth response in cattle and sheep.
Declining protein levels in the ration of growing-finishing steers has not altered their feedlot performance if the crude protein level, after steers reach 340 kg, does not drop below 8.3% of the dry matter Cahill, 1972, 1973) . This finding has the potential of saving considerable protein in the feeding of cattle.
Therefore, the objectives of this research were to measure the gain and efficiency response of steers implanted with various estrogens and related compounds while being fed a constant or declining level of supplemental protein.
EXPERIMENTAL PROCEDURES
Sixty-four Hereford steer calves (average initial weight 258 kg) were individually fed in this experiment. Since the steers had a fairly wide range in initial weight, they were allotted to treatments from heavy and light weight groups (n=32 each). The ration fed throughout the experiment consisted of limestone treated (.5%) corn silage , the supplement shown in table 1, constant or declining amounts of soybean meal , and a full-feed of dry whole shelled corn Implants of the following compounds were prepared using a process similar to the commercial DES implant (Rhodia Inc., Hess and Clark Division, Ashland, OH): stilbene s (S), estriol 6 (E3), estrone 6 (El), fl-estradiol 7 (/~-E2), a-estradiol 6 (a-E2) and diethylstilbestrol (DES). These implants were prepared in a poly-lactic acid, polyglycolic acid matrix. Additionally, the commercially available DES implant was used (Rhodia Inc.); the two DES implants will be referred to as DES-exptl and DES-comm, respectively. All implants contained 30 mg of the respective compound; these implants were placed subcutaneously behind the ear on day 0 and 84 of the experiment; control steers were not implanted.
Gain, feed intake and efficiency were measured throughout the 181 day experiment. Additionally jugular blood was collected at 1 pm on days 0, 14, 28, 56, 84, 98, 112 
RESULTS AND DISCUSSION
Since virtually all of the interaction effects were non-significant, only the main effects will be presented with limited discussion of observed interactions.
The gain response of these steers is shown in table 2. Both DES implants and 3-E2 implanted steers gained faster than controls over the total experiment. This response was significant (P<.10) at 49 days for the DES-comm implant and at 70 days for the 3-E2 (P<.05) and the DES-exptl (P<.10) implants. Thereafter, the response for these implant treatments was significant (P<.10 or <.05) for both DES implants and highly significant (P<.01) for the 3-E2 implant. The apparent gain reduction for the S implant during the first 21 days was significant (P=.10); thereafter the response of these steers was not different from the controls. The E3, E1 and a-E2 implants did not result in any significant gain responses at any point during the experiment; E1 appeared to give a small gain response (e.g., 4 to 7% above the controls) from 70 to 147 days. The gain response to both DES implants remained fairly constant (e.g., 10 to 15%) throughout the experiment, whereas the response to 3-E2 gradually increased (e.g., 12% up to 24%) during the course of the experiment.
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various implants followed the gain response pattern (table 3) . The ~-E2 implant resulted in the greatest improvement (P<.O1) and reached statistical significance (P<.05) after 70 days.
The efficiency response to the DES implants was less (P<.05 and <.10 for exptl and comm DES implants, respectively), although statistical significance was reached earlier (e.g., 49 days) than with the 3-E2 implant.
There was a significant interaction between implant and the initial weight group in gain and efficiency after 147 and 181 days. This was largely due to a small gain and efficiency response to S in the light weight steers and a gain and efficiency depression in the heavy weight steers; however, inspection of the individual data revealed one steer in the heavy group had a low rate of gain and dry matter conversion which accounted for the depression observed in this weight group.
The PUN response of these steers is shown in table 4. All values were adjusted by covariance to equal initial PUN level. Both DES implants and the /3-E2 implant resulted in a decrease in PUN (P<.05). This response was significant earlier with DES-exptl (14 days) than with/J-E2 (56 days); however, by 84 days, there was no significant difference in PUN levels. Following reimplantation on the 84th day, PUN was decreased 14 days later by ~J-E2 (P<.10) and DES-exptl (P<.05). Thereafter, there was no significant depression in PUN although the values were somewhat below the controls for the DES and/3-E2 implanted steers 28 days (112th day) after reimplantation. None of the other implants affected PUN.
Hematocrit was unaffected by the implant treatments; the average value for all samples was 37.2% with some tendency for the values to increase (P<.05) with time on experiment (35, 34, 37, 39, 38, 39 , 39%, respectively, for each bleeding).
Seminal vesicle gland weight (table 5) increased (P<.O01) with DES and ~-E2 implantation; it appears that maximum increase in weight resulted from these implants (Preston et al., 1971) . Seminal vesicle weight was not affected by S or ~-E2. On the other hand, E3 and E1 increased seminal vesicle weight (P~.001); however, this response was only 62 and 33% as great, respectively, as the average response to DES and/3-E2 (P<.001).
The gain and feed efficiency response of these steers was not altered by a declining level of crude protein in the ration (tables 2 and 3) . PUN, however, responded as expected (table 4) with higher values (P<.O01) when the higher level of protein was fed during the first 49 days, similar values when equal protein levels were fed from 50 to 98 days, and lower values (P<.001) when lower protein levels were fed from 99 to 181 days. Hematocrit was higher for steers fed the variable protein level on days 28 (P<.05), 56 (P<.10) and 112 (P<.05). Unexpectedly, the seminal vesicle weight of steers fed the declining supplemental protein level was heavier (P<.01) than from steers fed a constant level of supplemental protein.
Allotting these steers on the basis of initial weight significantly reduced the residual varia- 
Discussion
These data support the theory that estrogenic potency is required for growth stimulation in steers. DES and 3-estradiol both stimulated gain and feed efficiency, whereas compounds with lesser estrogenic potency (e.g., estrone and estriol) or no estrogenic potency (e.g., a-estradiol and stilbene) did not elicit a response. It is known that trans-DES, which is estrogenic, results in gain stimulation, whereas the non-estrogenic cis-isomer does not (Preston et al., 1971) . The response observed with /J-estradiol was greater than with DES. The PUN response also supports this view since the strong estrogens were the only compounds to depress PUN, a response that was related to time after implantation (Preston, 1968) . The seminal vesicle response of these steers indicates that estriol and estrone implantation resulted in 62 and 33% of the response observed with the potent estrogens, whereas no response was observed in steers implanted with c~-estradiol or stilbene. Thus, it would appear there is a dichotomy in response between gain stimulation and seminal vesicle response for various compounds. It may also be that a minimum estrogen level is required for gain stimulation that results in the seminal vesicle gland weight exceeding 25 to 30 grams.
The data presented here support the concept that protein levels in the ration of growingfinishing steers can be reduced during the feeding period without affecting feedlot performance. While higher protein levels (16.7 vs 13.5% of the dry matter) did not stimulate gains during the first 49 days, it should be noted that the initial weight of these steers was 258 kilograms. Feeding a lower level of crude protein (11.5 vs 13.5% of the dry matter) during the last 83 days of the feeding period did not alter the gain and feed efficiency response of these steers. Protein requirements for steers of this size range between 11.1 to 12.1% of the ration dry matter (N.R.C., 1976). The PUN levels continually increased in steers fed a constant level of supplemental protein, whereas steers fed a declining level tended to maintain a constant PUN level. Using a PUN level greater than 10 rag/100 ml as an indication of adequate protein intake (Preston et al., 1965 ), steers fed the declining level of supplemental protein were not wasting supplemental protein after 84 days, when their average weight was approximately 379 kilograms. Since gain was not increased by feeding a higher amount of protein during the first 49 days, it may be that 7 to 8 mg urea-N/100 ml plasma is the minimum PUN compatible with maximum feedlot performance since this is the PUN level observed in steers fed the constant level of supplemental protein during this period of time. 
